Welcome to MyStrategist

Quickly uncover the breadth and depth of the editorial offerings found only in MedTech Strategist and Market Pathways – the medtech industry’s leading sources of global business, regulatory, and reimbursement analysis and intelligence on an all-in-one, digital platform. Think Strategically. Subscribe Today

Subscribe Browse

Latest from Market Pathways

Global Medical Device Regulatory, Reimbursement, and Policy Review

Subscribe
View More
View More
Teaser Image
Pathways' Picks

CMS Departure, Apple 510(k) Questions, PCCPs on the Rise, and More

  • 1 days ago
  • David Filmore

In this week’s Pathways Picks: Long-time CMS coverage director Tamara Syrek Jensen leaves the agency; medtech reimbursement professional society formed; CPT code, NCD analysis updates; medtech reimbursement bills on Capitol Hill; Apple hypertension clearance; predetermined change plans; France’s evaluation principles for digital health; Africa advances continent-wide review; Europe updates borderline manual; and more global medtech policy updates.

Subscribe

Start a free trial and unlock 5-days of exclusive subscriber-only access to MedTech Strategist & Market Pathways

Start Trial

Latest from MedTech Strategist

Actionable intelligence exploring the people, challenges, and opportunities impacting the global medtech community.

Subscribe
View More
View More
Teaser Image
Regulatory & Reimbursement

The Digest: July 2025

  • 28 days ago
  • Colin Miller

In this month's news, 510(k)s for ENT devices, Zimmer Biomet buys Monogram, clearances for Tissium and Anaconda Biomed, and more.

Subscribe

Don't Just Advertise... Strategize!

Advertise with MedTech Strategist and be seen by medtech's most influential executives.

Learn More

Latest from Community Blog

MedTech Strategist's free Community Blog explores the passion behind the people, technologies, and companies impacting the global device space.

Subscribe
View More
View More
Teaser Image
Business Strategies

Sequel Preps for Full Launch of twist AID System

  • 29 days ago
  • Mary Thompson

With full commercial launch of its automated insulin delivery system expected by year’s end, Sequel’s VP of marketing provides details on the company’s competitive strategy and its future plans. Excerpted from our recent Q&A with Chris Gilbert.

View More

Our strategic publications provide actionable intelligence to support each member of your organization. Check to see if your company has access.

Learn More